Key biomarkers and latent pathways of dysferlinopathy: Bioinformatics analysis and in vivo validation

MLA

Yan Xie, et al. “Key Biomarkers and Latent Pathways of Dysferlinopathy: Bioinformatics Analysis and in Vivo Validation.” Frontiers in Neurology, vol. 13, Sept. 2022. EBSCOhost, https://doi.org/10.3389/fneur.2022.998251.

APA

Yan Xie, Ying-hui Li, Kai Chen, Chun-yan Zhu, Jia-ying Bai, Feng Xiao, Song Tan, & Li Zeng. (2022). Key biomarkers and latent pathways of dysferlinopathy: Bioinformatics analysis and in vivo validation. Frontiers in Neurology, 13. https://doi.org/10.3389/fneur.2022.998251

Chicago

Yan Xie, Ying-hui Li, Kai Chen, Chun-yan Zhu, Jia-ying Bai, Feng Xiao, Song Tan, and Li Zeng. 2022. “Key Biomarkers and Latent Pathways of Dysferlinopathy: Bioinformatics Analysis and in Vivo Validation.” Frontiers in Neurology 13 (September). doi:10.3389/fneur.2022.998251.